Patient Preference for Pegfilgrastim (Neulasta®) Application Forms

NACompletedINTERVENTIONAL
Enrollment

404

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

September 10, 2019

Study Completion Date

September 10, 2019

Conditions
Non Hodgkin LymphomaBreast Cancer
Interventions
DEVICE

On-body injector

Medical device for subcutaneous injection of a supportive medicine (Pegfilgrastim) automatically after 27 hours after application of device.

DEVICE

Pre-filled syringe

For subcutaneous injection of a supportive medicine (Pegfilgrastim).

Trial Locations (48)

10367

Research Site, Berlin

15236

Research Site, Frankfurt (Oder)

18107

Research Site, Rostock

18435

Research Site, Stralsund

24939

Research Site, Flensburg

26121

Research Site, Oldenburg

29223

Research Site, Celle

30161

Research Site, Hanover

31134

Research Site, Hildesheim

34119

Research Site, Kassel

37073

Research Site, Göttingen

38642

Research Site, Goslar

38820

Research Site, Halberstadt

40878

Research Site, Ratingen

44623

Research Site, Herne

45468

Research Site, Mülheim

47441

Research Site, Moers

47805

Research Site, Krefeld

48527

Research Site, Nordhorn

49124

Research Site, Georgsmarienhütte

52146

Research Site, Würselen

52222

Research Site, Stolberg

53111

Research Site, Bonn

56727

Research Site, Mayen

63069

Research Site, Offenbach

63739

Research Site, Aschaffenburg

66538

Research Site, Neunkirchen

67655

Research Site, Kaiserslautern

68165

Research Site, Mannheim

69120

Research Site, Heidelberg

73760

Research Site, Ostfildern

78224

Research Site, Singen

79110

Research Site, Freiburg im Breisgau

80639

Research Site, München

86150

Research Site, Augsburg

94036

Research Site, Passau

98646

Research Site, Hildburghausen

99084

Research Site, Erfurt

99610

Research Site, Sömmerda

99974

Research Site, Mühlhausen

01127

Research Site, Dresden

01307

Research Site, Dresden

06110

Research Site, Halle

06366

Research Site, Köthen

04683

Research Site, Naunhof

01844

Research Site, Neustadt in Sachsen

08525

Research Site, Plauen

03130

Research Site, Spremberg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

iOMEDICO AG

INDUSTRY

NCT03619993 - Patient Preference for Pegfilgrastim (Neulasta®) Application Forms | Biotech Hunter | Biotech Hunter